Incidence rate and predictors of COVID-19 in the two largest cities of Burkina Faso - prospective cohort study in 2021 (ANRS-COV13).
Fiche publication
Date publication
juin 2023
Journal
BMC infectious diseases
Auteurs
Membres identifiés du Cancéropôle Est :
Dr DABAKUYO-YONLI Sandrine, Dr BILLA Oumar
Tous les auteurs :
Kaboré NF, Ouédraogo S, Mamguem AK, Traoré IT, Kania D, Badolo H, Sanou G, Koné A, Yara M, Kagoné T, Ouédraogo E, Konaté B, Médah R, de Rekeneire N, Poda A, Diendéré AE, Ouédraogo B, Billa O, Paradis G, Dabakuyo-Yonli TS, Tinto H
Lien Pubmed
Résumé
Early data on COVID-19 (based primarily on PCR testing) indicated a low burden in Sub-Saharan Africa. To better understand this, this study aimed to estimate the incidence rate and identify predictors of SARS-CoV-2 seroconversion in the two largest cities of Burkina Faso. This study is part of the EmulCOVID-19 project (ANRS-COV13).
Mots clés
Africa, Burkina Faso, COVID-19 incidence, SARS-CoV-2, Sero-epidemiology
Référence
BMC Infect Dis. 2023 06 12;23(1):394